Pdt Partners, LLC Neogenomics Inc Transaction History

Pdt Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $525,108 - $821,864	-14,554 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.26 - $40.48 $251,645 - $306,271	7,566 Added 108.27%	14,554 $537,000
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $169,179 - $216,767	6,988 New	6,988 $216,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.